Annual CFF
Summary
- Current Value
- As of today, NVAX annual cash from financing is $260.58M, up +3134.24% on
- Historical Performance
- NVAX annual cash from financing is down -43.56% over the past 3 years, and up +164.86% over the past 5 years
- All-Time High Comparison
- NVAX annual cash from financing is currently -73.54% below its historical high of $984.76M set on
- 3-Year Low Comparison
- NVAX annual cash from financing is +3134.24% above its 3-year low of $8.06M reached on
- Sector Comparison
- NVAX annual cash from financing is higher than 92.36% of companies in Healthcare sector
Cash From Financing Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | $260.58M | +3134.2% | -43.6% | +164.9% | +516.1% | |
| Quarterly Cash From Financing | $42.44M | +10000.0% | +237.0% | +289.6% | +122.9% | |
| TTM Cash From Financing | $30.92M | -91.5% | -57.5% | -94.9% | -28.9% | |
| Price | $7.78 | -9.0% | -36.7% | -93.9% | -84.5% | |
| Annual Cash From Operations | -$87.26M | +87.8% | -127.0% | +36.1% | -165.8% | |
| Annual Cash From Investing | -$204.04M | -247.0% | -303.7% | -630.1% | -8764.0% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual Total Debt | $263.47M | -6.1% | -49.7% | -20.6% | +10000.0% | |
| Shares Outstanding | 162.50M | +1.3% | +88.9% | +129.0% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $324.99M | N/A | -19.8% |
| 5Y | $984.76M | N/A | -73.5% |
| All | $984.76M | -73.5% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $8.06M | +3134.2% | |
| 5Y | $8.06M | +3134.2% | |
| All | -$720.00K | >+9999.0% |
Cash From Financing History
FAQ
What is the current annual cash from financing of NVAX?
As of today, NVAX annual cash from financing is $260.58M
What is 1-year change in NVAX annual cash from financing?
NVAX annual cash from financing is up +3134.24% year-over-year
What is 3-year change in NVAX annual cash from financing?
NVAX annual cash from financing is down -43.56% over the past 3 years
How far is NVAX annual cash from financing from its all-time high?
NVAX annual cash from financing is currently -73.54% below its historical high of $984.76M set on December 31, 2020
How does NVAX annual cash from financing rank versus sector peers?
NVAX annual cash from financing is higher than 92.36% of companies in Healthcare sector
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly CFF
Summary
- Current Value
- As of today, NVAX quarterly cash from financing is $42.44M, up +4180.96% on
- Historical Performance
- NVAX quarterly cash from financing is up +43854.64% year-over-year, and up +237.02% over the past 3 years
- All-Time High Comparison
- NVAX quarterly cash from financing is currently -92.64% below its historical high of $576.99M set on
- 3-Year Low Comparison
- NVAX quarterly cash from financing is +112.10% above its 3-year low of -$350.79M reached on
- Sector Comparison
- NVAX quarterly cash from financing is higher than 90.47% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | $42.44M | +4181.0% | +10000.0% | +237.0% | +289.6% | |
| Annual Cash From Financing | $260.58M | – | +3134.2% | -43.6% | +164.9% | |
| TTM Cash From Financing | $30.92M | +366.1% | -91.5% | -57.5% | -94.9% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| Quarterly Cash From Operations | $107.80M | +184.6% | +174.4% | +378.5% | +1759.3% | |
| Quarterly Cash From Investing | -$136.53M | -222.9% | -527.8% | -362.5% | -35.6% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $251.14M | +9.9% | +7.6% | -42.7% | -43.5% | |
| Shares Outstanding | 162.50M | – | +1.3% | +88.9% | +129.0% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $42.44M | at high | |
| 3Y | $258.22M | -83.6% | |
| 5Y | $576.99M | -92.6% | |
| All | $576.99M | -92.6% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$7.06M | +701.1% | |
| 3Y | -$350.79M | +112.1% | |
| 5Y | -$350.79M | +112.1% | |
| All | -$350.79M | +112.1% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of NVAX?
As of today, NVAX quarterly cash from financing is $42.44M
What is NVAX quarterly cash from financing most recent change?
NVAX quarterly cash from financing was up +4180.96% on September 30, 2025
What is 1-year change in NVAX quarterly cash from financing?
NVAX quarterly cash from financing is up +43854.64% year-over-year
How far is NVAX quarterly cash from financing from its all-time high?
NVAX quarterly cash from financing is currently -92.64% below its historical high of $576.99M set on March 31, 2021
How does NVAX quarterly cash from financing rank versus sector peers?
NVAX quarterly cash from financing is higher than 90.47% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
TTM CFF
Summary
- Current Value
- As of today, NVAX TTM cash from financing is $30.92M, up +366.08% on
- Historical Performance
- NVAX TTM cash from financing is down -91.51% year-over-year, and down -57.55% over the past 3 years
- All-Time High Comparison
- NVAX TTM cash from financing is currently -97.75% below its historical high of $1.38B set on
- 3-Year Low Comparison
- NVAX TTM cash from financing is +116.65% above its 3-year low of -$185.67M reached on
- Sector Comparison
- NVAX TTM cash from financing is higher than 74.23% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | $30.92M | +366.1% | -91.5% | -57.5% | -94.9% | |
| Annual Cash From Financing | $260.58M | – | +3134.2% | -43.6% | +164.9% | |
| Quarterly Cash From Financing | $42.44M | +4181.0% | +10000.0% | +237.0% | +289.6% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| TTM Cash From Operations | -$378.32M | +40.0% | -316.3% | +40.9% | -707.4% | |
| TTM Cash From Investing | $45.26M | -78.8% | +112.7% | +151.8% | +113.0% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $251.14M | +9.9% | +7.6% | -42.7% | -43.5% | |
| Shares Outstanding | 162.50M | – | +1.3% | +88.9% | +129.0% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $260.58M | N/A | -88.1% |
| 3Y | $561.61M | -94.5% | |
| 5Y | $1.38B | -97.8% | |
| All | $1.38B | -97.8% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$11.62M | +366.1% | |
| 3Y | -$185.67M | +116.7% | |
| 5Y | -$185.67M | +116.7% | |
| All | -$185.67M | +116.7% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of NVAX?
As of today, NVAX TTM cash from financing is $30.92M
What is NVAX TTM cash from financing most recent change?
NVAX TTM cash from financing was up +366.08% on September 30, 2025
What is 1-year change in NVAX TTM cash from financing?
NVAX TTM cash from financing is down -91.51% year-over-year
How far is NVAX TTM cash from financing from its all-time high?
NVAX TTM cash from financing is currently -97.75% below its historical high of $1.38B set on March 31, 2021
How does NVAX TTM cash from financing rank versus sector peers?
NVAX TTM cash from financing is higher than 74.23% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
Cash From Financing Formula
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax
